Preeti Narayan, MD (@pre_ryan) header
Preeti Narayan, MD (@pre_ryan) profile picture

Preeti Narayan, MD

@pre_ryan

Breast Oncologist at FDA, @FDAOncology Opinions are my own. Canadian/American hybrid 🇨🇦🇺🇸

 Washington, DC
fda.gov/about-fda/fda-organization/oncology-center-excellence
Joined February 2015
  • Tweets182
  • Following101
  • Followers380
28Media
Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)Photo by Preeti Narayan, MD (@pre_ryan)
Preeti Narayan, MD retweeted
Dr. Kelly Shanahan (@stage4kelly) profile picture
Dr. Kelly Shanahan@stage4kelly12 Dec 2024
Unfortunately, other obligations kept me and @JaniceTNBCmets from attending our favorite @abreastcancer session with the FDA, but nothing could keep us from at least saying hi to some of our favorite @FDAOncology people! @tmprowell #SABCS24
Image from Dr. Kelly Shanahan (@stage4kelly)
Image from Dr. Kelly Shanahan (@stage4kelly)
5
1
23
4,099
Preeti Narayan, MD retweeted
Julia Maués (@itsnot_pink) profile picture
Julia Maués@itsnot_pink5 May 2024
“Dose is the foundation of drug development. Having the wrong dose is like building a house on quicksand.” @realrickpazdur, quoted by @pre_ryan at @NBCCStopBC’s #NBCCSummit.
Image from Julia Maués (@itsnot_pink)
Image from Julia Maués (@itsnot_pink)
1
9
27
1,391
Today’s #NBCCSummit panel includes @theNCI’s Larissa Korde, @pre_ryan, NBCC team leader Nicole Seagriff, and @QueensGlobalOnc’s Brooke Wilson about why oncology research should be designed to answer questions about outcomes and questions that matter for patients.
Image from National Breast Cancer Coalition (@NBCCStopBC)
1
3
6
576
Preeti Narayan, MD retweeted
Harpreet Singh, MD (@harpreet_md) profile picture
Harpreet Singh, MD@harpreet_md3 May 2024
✨Perfect day spending time with colleagues and friends ✨@FDAOncology
Image from Harpreet Singh, MD (@harpreet_md)
1
17
960
I want to say I appreciate @FDAOncology coming out from behind the curtain and discussing with patients and clinicians their thoughts & rationale around recent approvals. Great session, @SABCSSanAntonio 👏🏻
3
11
1
57
9,747
Preeti Narayan, MD retweeted
Oncology Brothers (@OncBrothers) profile picture
Oncology Brothers
@OncBrothers6 Dec 2023
#SABCS23 Day 1 Highlights #CommunityOnc: @FDAOncology Review on recent approvals 1. #CAPItello291 2. #EMERALD 3. #TDxD 4. Tumor Agnostic landscape 5. Post CDK4/6i HR+ @SABCSSanAntonio @VivekSubbiah @VKaklamani @JaniceTNBCmets #bcsm @DrSGraff @oreganruth 1/6
Image from Oncology Brothers (@OncBrothers)
2
38
1
104
16,118
Preeti Narayan, MD retweeted
Elisa Agostinetto (@ElisaAgostinett) profile picture
Elisa Agostinetto@ElisaAgostinett5 Dec 2023
Great start at #SABCS23 with the session on New approval in metastatic #breastcancer 🔸Elacestrant 🔸T-DXd 🔸Capivasertib Happening now at Hemisfair Ballroom 1-2 @SABCSSanAntonio @OncoAlert
Image from Elisa Agostinetto (@ElisaAgostinett)
6
18
1,651
Preeti Narayan, MD retweeted
GRASP (@GRASPtweets) profile picture
GRASP@GRASPtweets6 Dec 2022
Don’t miss the GRASP-SABCS Reception happening in 20 MINUTES from 6-7:30pm in Room 220 (Cantilever Room)! Clinicians, researchers, and advocates are all invited!! #SABCS22
Image from GRASP (@GRASPtweets)
2
4
1
40
Preeti Narayan, MD retweeted
Christine Hodgdon (@christeeny513) profile picture
Christine Hodgdon@christeeny5135 Jun 2022
Attending the patient advocacy session with @FDAOncology & Dr Richard Pazdur made a poignant statement that all advocate communities should hear - we need to redefine the word “tolerable” when discussing side effects. Could not agree more! #ASCO22 #BCSM
3
17
5
86
Preeti Narayan, MD retweeted
@gulleyj1 (@gulleyj1) profile picture
@gulleyj1@gulleyj12 Jun 2022
Delighted to be partnering with @pre_ryan for an #ASCO22 session on Finding Your Niche in Oncology: Careers in Government in Trainee Lounge. @US_FDA @FDAOncology @theNCI @NCIResearchCtr
Image from @gulleyj1 (@gulleyj1)
2
4
49
This FDA Approval Summary gives you a look into the minds (or more importantly statistcal analysis) of the FDA breast team that reviewed #MONARCHE. Worth a read! @OncoAlert #bcsm cc. @ErikaHamilton9 ascopubs.org/doi/abs/10.1200…
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer

FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer

PURPOSEThe US Food and Drug Administration approved abemaciclib in combination with endocrine therapy (ET) for the adjuvant treatment of adult patients with hormone receptor–positive, human epidermal...

ascopubs.org
1
25
3
49
Preeti Narayan, MD retweeted
The Hollywood Reporter (@THR) profile picture
The Hollywood Reporter
@THR31 Dec 2021
The iconic and beloved Betty White has died at 99. Read all about her legendary legacy: thr.cm/vYZhSIW
Image from The Hollywood Reporter (@THR)
63
1,264
612
5,034
There’s a cultural perception in drug development that enrolling a diverse, heterogeneous patient cohort can be “risky” for detecting drug effects—a perception that needs to go away, said @LolaFashoyinAje. cancerletter.com/conversatio…
7
9
Preeti Narayan, MD retweeted
U.S. FDA (@FDA) profile picture
U.S. FDA
@FDA28 May 2021
Today, FDA approved the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy. go.usa.gov/x6CVW
Image from U.S. FDA (@FDA)
6
91
25
163
Preeti Narayan, MD retweeted
ACS Journal Cancer (@JournalCancer) profile picture
ACS Journal Cancer@JournalCancer11 May 2021
In this edition of #FirstPerson, we feature Richard Pazdur, MD (@realrickpazdur), founding director of the @FDAOncology Center of Excellence, who has long spearheaded major initiatives to improve oncology drug development. Read more about his impact: acsjournals.onlinelibrary.wi…
Image from ACS Journal Cancer (@JournalCancer)
7
1
25
Preeti Narayan, MD retweeted
Danielle Krol, MD (@DanielleKrolMD) profile picture
Danielle Krol, MD@DanielleKrolMD17 Feb 2021
The OCE Patient-Friendly Language Project began with a vision that one day commonly used clinical trials terms could be defined so they are easier for patients and healthcare providers to understand. So happy to see this resource now available 👇🏻 – at Washington, DC
This Post is from an account that no longer exists. Learn more
3
2
Preeti Narayan, MD retweeted
Danielle Krol, MD (@DanielleKrolMD) profile picture
Danielle Krol, MD@DanielleKrolMD5 Dec 2020
Great opportunities for advocates this year at #SABCS20! I will be moderating a Q&A with 4 members of the FDA Oncology Breast Cancer team on Thurs 12/10 at Noon! Please ask your questions below, and I will ask them LIVE to the panel 👇🏻 @SABCSSanAntonio @abreastcancer – at Washington, DC
Image from Danielle Krol, MD (@DanielleKrolMD)
4
10
3
22
Preeti Narayan, MD retweeted
Medium Rare (@MediumRareDC) profile picture
Medium Rare@MediumRareDC11 Nov 2020
Given the new rules for smaller holiday gatherings , If you know anyone over 70 that will be alone for Thanksgiving in the DMV area , we will deliver them a free Thanksgiving dinner . Email us name , address and cell phone. [email protected] – at Bethesda, MD
92
1,275
257
3,747
Preeti Narayan, MD retweeted
Jeopardy! (@Jeopardy) profile picture
Jeopardy!
@Jeopardy8 Nov 2020
Jeopardy! is saddened to share that Alex Trebek passed away peacefully at home early this morning, surrounded by family and friends. Thank you, Alex.
Image from Jeopardy! (@Jeopardy)
24,853
175,506
214,890
642,746
Preeti Narayan, MD retweeted
Julia Beaver (@DrJuliaBeaver) profile picture
Julia Beaver@DrJuliaBeaver7 Oct 2020
New @fdaoncology draft guidance: #clinicaltrials should be inclusive of premenopausal women with #breastcancer #bcsm .@drjennifergao @pre_ryan @DanielleKrolMD @LalehAmiri
This Post is from an account that no longer exists. Learn more
8
1
11
Load more